Emerging role of EGFR and lung cancer treatments

Abstract

Cancer incidence rates are growing rapidly globally and according to the estimation from the World Health Organization (WHO), there will be 21.7 million people diagnosed with cancer. At present, cancer is the second leading cause of death around the globe. Most of the increase is expected to be concentrated in developing countries due to heavy smoking, poor diet, physical inactivity and environmental pollutions. In 2012, it was observed that the lung cancer was among the 10 most commonly founded cancers that are frequently diagnosed worldwide (Lung cancer statistics). The third-most commonly diagnosed cancer in both men and women is the lung cancer (Cancer statistics, 2017).